Quality of Life in Patients With Bladder Cancer
Recruitment status was: Recruiting
RATIONALE: Studying quality of life in patients with bladder cancer may help determine the long-term effects of bladder cancer and may help improve the quality of life for patients in the future.
PURPOSE: This clinical trial is studying quality of life in patients with bladder cancer.
Procedure: quality-of-life assessment
Procedure: questionnaire administration
|Official Title:||Bladder Cancer Prognosis Programme (Incorporating SELENIB Trial) [QOL]|
- Quality of life as measured by EORTC QLQ-C30, QLQ-BLS24, and QLQ-BLM30 questionnaires
|Study Start Date:||December 2005|
- To study the effects of recurrence and progression on health-related quality of life (HRQL).
- To study the effects of repeat cystoscopy on HRQL.
- To study the patients' assessments of a hypothetical prognostic model and how this affects their preference for the mode of surveillance.
OUTLINE: This is a multicenter study.
Quality-of-life questionnaires developed by the European Organization for Research and Treatment for Cancer (EORTC) will be used. The EORTC QLQ-BLS24 with 24 questions specific to non-muscle-invasive bladder cancer and the EORTC QLQ-BLM30 with 30 questions specific to muscle-invasive bladder cancer will be combined and used in conjunction with the general cancer questionnaire QLQ-C30.
Assessments using the QLQ-C30 will be made at baseline in the entire cohort of patients. Follow-up assessments using the QLQ-C30, QLQ-BLS24, and QLQ-BLM30 167 will be made at first routine follow-up and annually until the end of study.
Peer Reviewed and Funded or Endorsed by Cancer Research UK.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00553215
|University of Birmingham||Recruiting|
|Birmingham, England, United Kingdom, B15 2TH|
|Contact: Maurice Zeegers, MD 44-121-414-6721|
|Study Chair:||Maurice Zeegers, MD||University of Birmingham|